tetano
Editor, Senior Moderator
Am J Transplant
. 2021 Sep 23.
doi: 10.1111/ajt.16855. Online ahead of print.
Reconciling short-term clinical and Immunological outcomes of SARS-CoV-2 vaccination in Solid Organ Transplant recipients
Oriol Bestard[SUP] 1 2 [/SUP], Thomas Jouve[SUP] 2 [/SUP], Lluís Castells[SUP] 3 4 [/SUP], Manuel Lopez[SUP] 5 [/SUP], Marina Muñoz[SUP] 6 [/SUP], Elena Crespo[SUP] 2 [/SUP], Nestor Toapanta[SUP] 1 [/SUP], Juliana Esperalba[SUP] 7 [/SUP], Isabel Campos-Varela[SUP] 3 4 [/SUP], Teresa Pont[SUP] 7 [/SUP], Oscar Len[SUP] 7 [/SUP], Magda Campins[SUP] 8 [/SUP], Francesc Moreso[SUP] 1 2 [/SUP]
Affiliations
Abstract
Relevant concerns are being raised regarding the weak serological response of solid organ transplant (SOT) recipients after receiving two doses of messenger RNA-based vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1) and some severe cases of coronavirus disease (COVID-19) occurring after vaccination (2). Thus, additional preventive booster doses are proposed to enhance anti-viral immunity.
. 2021 Sep 23.
doi: 10.1111/ajt.16855. Online ahead of print.
Reconciling short-term clinical and Immunological outcomes of SARS-CoV-2 vaccination in Solid Organ Transplant recipients
Oriol Bestard[SUP] 1 2 [/SUP], Thomas Jouve[SUP] 2 [/SUP], Lluís Castells[SUP] 3 4 [/SUP], Manuel Lopez[SUP] 5 [/SUP], Marina Muñoz[SUP] 6 [/SUP], Elena Crespo[SUP] 2 [/SUP], Nestor Toapanta[SUP] 1 [/SUP], Juliana Esperalba[SUP] 7 [/SUP], Isabel Campos-Varela[SUP] 3 4 [/SUP], Teresa Pont[SUP] 7 [/SUP], Oscar Len[SUP] 7 [/SUP], Magda Campins[SUP] 8 [/SUP], Francesc Moreso[SUP] 1 2 [/SUP]
Affiliations
- PMID: 34554648
- DOI: 10.1111/ajt.16855
Abstract
Relevant concerns are being raised regarding the weak serological response of solid organ transplant (SOT) recipients after receiving two doses of messenger RNA-based vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1) and some severe cases of coronavirus disease (COVID-19) occurring after vaccination (2). Thus, additional preventive booster doses are proposed to enhance anti-viral immunity.